06/03/2025 09:24

Fisher & Paykel Corp (FPH) $31.25

We discussed FPH in detail through February, believing the stock has priced in a worst-case Trump scenario after correcting over 16%.

Read more

27/02/2025 09:19

Fisher & Paykel (FPH) $31.47

FPH is one ASX company that Trump's tariffs have hit due to its exposure to Mexico, but with much of the risk already priced in the FPH share price following the ~15% correction, we can see surprises now on the upside.

Read more

04/02/2025 09:45

Fisher & Paykel Corp (FPH) $31.80

We touched on FPH in yesterdays Match Out Report, the drop yesterday of 7.4% was logical considering the companies exposure to Mexico but three things are sitting positively with us this morning:

Read more

03/02/2025 17:15

Fisher and Paykel (FPH) $31.80

Read more

10/10/2024 09:05

Fisher & Paykel Healthcare (FPH) $32.89

Auckland-based FPH has strong earnings growth, with an impressive 3-year compounded annual growth (CAGR) of 29%. This growth is driven by double-digit revenue growth in Hospitals and Homecare, with margin expansion underpinning the stock's strong investment case. The company's superior earnings growth means FPH should maintain a significant valuation (P/E) premium to the region's large-cap healthcare peers. However, this is starting to look stretched as the stock pushes towards $35.

Read more

22/08/2024 09:22

Fisher & Paykel Healthcare Corp (FPH) $29.43

We liked FPH’s report in May, with double-digit revenue growth and improving margins underpinning a strong resurgence in earnings – we covered the FPH result at the time, liking what we read. We can see FPH trading well above $30 into the new FY, and we like the stock back around $28.

Read more

27/06/2024 09:55

Fisher & Paykel Healthcare Corp (FPH) $27.84

We liked FPH’s report in May, with double digit revenue growth and improving margins underpinning a strong resurgence in earnings  - we covered the details of the FPH report last Thursday.

Read more

20/06/2024 09:43

Fisher & Paykel Healthcare Corp (FPH) $28.82

FPH’s report in May was well received by the market, as earnings growth really kicked up a notch driven by double-digit revenue growth in Hospitals and Homecare, along with solid expansion in margins.

Read more

07/11/2023 09:14

Fisher & Paykel Corp Ltd (FPH) $20.77

Medical device company FPH swung around dramatically into and out of COVID. The stock is not cheap, trading at 52x for FY 2024, especially as it experiences slower gross margin recovery and lower Hospital consumable sales. The stock looks “ok” value trading ~$20, it's not compelling to us.

Read more

29/11/2022 09:03

Fisher & Paykel Healthcare Corp Ltd (FPH) $19.20

FPH like Ansell has also more than halved from its post-Covid high, again taking it below levels seen before the outbreak of the pandemic. Arguably the largest issue is the stocks trading on a lofty 60x valuation for 2023 in a period where value contraction has been the main game in town, revenue growth targets are solid but we question if they are already built into the share price as it approaches $20.The stock was extremely popular during the Covid panic due to its dominance of respiratory care products but the business has failed to deliver the lift in profits many expected and it’s just not overly exciting around current levels. • We believe a degree of value has been restored to FPH but the risk/reward isn’t exciting after the stock bounced over 20%.

Read more